Ventyx Biosciences
Cash Flow

Last updated:

Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Ventyx Biosciences generated cash of -$166,522,000, which is less than the previous year. Cash used in financing activities reached the amount of $53,329,000 last year. Net change in cash is therefore -$12,265,000.

Cash Flow

Ventyx Biosciences, Inc. (NASDAQ:VTYX): Cash Flow
2019 -2.64M 0 2.95M
2020 -6.19M 0 6.13M
2021 -38.65M -214.36M 323.55M
2022 -98.77M -74.93M 167.77M
2023 -166.52M 100.94M 53.32M

VTYX Cash Flow Statement (2019 – 2023)

2023 2022 2021 2020 2019
Cash at beginning of period
64.81M70.79M244K309K0
Operating activities
Net income
-192.96M-108.42M-83.74M-28.17M-4.32M
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
941K470K30K00
Stock-based compensation expense
28.58M16.57M2.73M45K198K
Deferred income tax benefit 28.58M16.57M2.73M45K198K
Changes in operating assets and liabilities:
Accounts receivable, net
00000
Inventories
00000
Accounts payable
-745K1.61M2.44M591K361K
Cash generated by operating activities
-166.52M-98.77M-38.65M-6.19M-2.64M
Investing activities
Purchases Of Investments
-272.27M-347.23M-232.50M00
Investments In Property Plant And Equipment
-514K-275K-262K00
Acquisitions Net
074.65K1.89M00
Cash generated by investing activities
100.94M-74.93M-214.36M00
Financing activities
Common Stock Issued
48.40M165.39M158.81M2K1K
Payments for dividends
00000
Repurchases of common stock
00000
Repayments of term debt
00-450K-6.12M2.95M
Cash used in financing activities
53.32M167.77M323.55M6.13M2.95M
Net Change In Cash
-12.26M-5.97M70.54M-65K309K
Cash at end of period
52.55M64.81M70.79M244K309K
Data sourceData sourceData source